Learning to control cyclophosphamide induced cystitis.
Hahn
Noah M
NM
D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use; D003556:Cystitis / Q000139:chemically induced* / Q000517:prevention & control*; D005260:Female; D005544:Forecasting; D006801:Humans; D008297:Male; D016328:NF-kappa B / Q000008:administration & dosage*; D009369:Neoplasms / Q000188:drug therapy; D011322:Primary Prevention / Q000379:methods / Q000639:trends; D018570:Risk Assessment; D016896:Treatment Outcome
D016328:NF-kappa B; D003520:Cyclophosphamide